Tower Research Capital (TRC)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$372K Buy
2022
Q1
$31K Sell
2021
Q4
$309K Buy
2021
Q3
$324K Buy
2021
Q2
$158K Sell
2021
Q1
$319K Buy
2020
Q4
$327K Buy
2020
Q3
$96K Sell
2020
Q2
$332K Buy
2020
Q1
Sell
2019
Q4
$35K Sell
2019
Q3
$58K Buy
2019
Q2
$25K Buy